Geode Capital Management LLC Acquires 45,155 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Geode Capital Management LLC raised its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 2.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,936,751 shares of the company’s stock after buying an additional 45,155 shares during the quarter. Geode Capital Management LLC owned about 2.26% of Pediatrix Medical Group worth $22,452,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Quest Partners LLC increased its holdings in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after buying an additional 622 shares during the period. nVerses Capital LLC bought a new stake in shares of Pediatrix Medical Group during the 2nd quarter valued at approximately $31,000. Innealta Capital LLC bought a new stake in shares of Pediatrix Medical Group during the 2nd quarter valued at approximately $33,000. Quarry LP grew its holdings in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, CWM LLC grew its holdings in shares of Pediatrix Medical Group by 134.0% during the 3rd quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after purchasing an additional 3,681 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total transaction of $129,728.00. Following the sale, the executive vice president now directly owns 135,810 shares of the company’s stock, valued at $2,172,960. This represents a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Mark S. Ordan sold 27,600 shares of the company’s stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total transaction of $423,660.00. Following the sale, the director now directly owns 138,683 shares in the company, valued at approximately $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

MD has been the topic of several research reports. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. Macquarie began coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Mizuho lifted their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, Jefferies Financial Group lifted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $16.42.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $13.49 on Friday. The firm has a market capitalization of $1.16 billion, a PE ratio of -4.41, a price-to-earnings-growth ratio of 2.00 and a beta of 1.57. The firm has a fifty day simple moving average of $14.29 and a two-hundred day simple moving average of $11.15. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.83. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $16.41.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same quarter in the prior year, the business posted $0.29 EPS. The business’s revenue was up .9% compared to the same quarter last year. Analysts forecast that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.